With the advancement of scientific research, more and more companies are choosing to invest in numerous medical fields, especially cancer research. One such company that has been making a significant contribution to the world of cancer research is Seattle Genetics, led by Clay Siegall. The company is geared towards the development of new research and new cancer treatments, with an aim to eventually find out more substantial knowledge on how to prevent and treat this disease which claims millions of lives every year.
Clay Siegall is the man behind Seattle Genetics and the person responsible for the success of the company. Over the past three years, under his leadership, Seattle Genetics has had their stock go up almost threefold.
Clay’s passion for leading Seattle Genetics and developing a right course of treatment for the disease is because Clay’s main aim in life is to ultimately help people and ease the pain they might face as a result of cancer. Clay strives to help as many people as he can through Seattle Genetics and ultimately help revolutionise the course of treatment for cancer. His commitment to transforming the cancer treatment industry has led Seattle Genetics to develop some of the most advanced and cutting edge technology which can be implemented for the treatment of one of the world’s most deadly diseases.
His tremendous commitment and drive to help people surfaces in the numerous endeavors Clay has undertaken under the cap of Seattle Genetics. In the past, Clay has personally raised over $1.2 billion towards cancer research and development of effective treatments. He has been praised by numerous organizations and media outlets for his dedication and contribution to the field of medical research. He has received numerous awards for this effort, such as the University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences. Also, he has received numerous awards for his leadership, including the Pacific Northwest Ernst & Young Entrepreneur of the Year award. Combining his love for scientific research and his exceptional leadership skills, Clay has managed to propel Seattle Genetics forward in a favorable direction.